Clinical Trial Update: Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL [Phase 3]

View source ↗

Summary

Phase 3 trial comparing R-CHOP alone versus R-CHOP followed by R-DHAP in untreated mantle cell lymphoma is reporting and updating efficacy data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Adriamycin (doxorubicin)
• CYTARABINE (CYTARABINE)
• Cytoxan (cyclophosphamide)
• Decadron (Dexamethasone)
• Deltasone (prednisone)
• Oncovin (vincristine)
• Platinol (cisplatin)
• Rituxan (rituximab)

Snippet

Sponsor: European Mantle Cell Lymphoma Network | Conditions: Lymphoma, Mantle-Cell | Phase 3 | Status: UNKNOWN